Ruochen Li

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Gas Chromatography

Helicobacter Pylori Infection

Immune Response

Top Venues

British journal of cancer

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Yun Gu, Mengyao Sun, Hanji Fang, Fei Shao, Chao Lin, Hao Liu, He Li, Hongyong He, Ruochen Li, Jieti Wang, Heng Zhang, Jiejie Xu
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer. British journal of cancer (2024)
Yun Gu, Mengyao Sun, Hanji Fang, Fei Shao, Chao Lin, Hao Liu, He Li, Hongyong He, Ruochen Li, Jieti Wang, Heng Zhang, Jiejie Xu
Impact of clonal TP53 mutations with loss of heterozygosity on adjuvant chemotherapy and immunotherapy in gastric cancer. British journal of cancer (2024)
Xin Liu, Kunpeng Lv, Jieti Wang, Chao Lin, Hao Liu, Heng Zhang, He Li, Yun Gu, Ruochen Li, Hongyong He, Jiejie Xu
C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer. British journal of cancer (2023)
Mengyao Sun, Yun Gu, Hanji Fang, Fei Shao, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Jieti Wang, Hao Liu, Jiejie Xu
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer. Cancer science (2023)
Mengyao Sun, Yun Gu, Hanji Fang, Fei Shao, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Jieti Wang, Hao Liu, Jiejie Xu
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer. Cancer science 115 (3) (2023)
Kunpeng Lv, Mengyao Sun, Hanji Fang, Jieti Wang, Chao Lin, Hao Liu, Heng Zhang, He Li, Hongyong He, Yun Gu, Ruochen Li, Fei Shao, Jiejie Xu
Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer. Journal for immunotherapy of cancer 11 (11) (2023)
Puran Zhang, Yun Gu, Jieti Wang, Kunpeng Lv, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Hao Liu, Jiejie Xu
Complement receptor C5aR1 blockade reprograms tumor-associated macrophages and synergizes with anti-PD-1 therapy in gastric cancer. International journal of cancer (2023)
Mengyao Sun, Yun Gu, Hanji Fang, Fei Shao, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Jieti Wang, Hao Liu, Jiejie Xu
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer. Cancer science 115 (3) (2023)
Mengyao Sun, Yun Gu, Hanji Fang, Fei Shao, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Jieti Wang, Hao Liu, Jiejie Xu
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer. Cancer science 115 (3) (2023)
Mengyao Sun, Yun Gu, Hanji Fang, Fei Shao, Chao Lin, Heng Zhang, He Li, Hongyong He, Ruochen Li, Jieti Wang, Hao Liu, Jiejie Xu
Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer. Cancer science 115 (3) (2023)
Kuan Yu, Yun Gu, Puran Zhang, Hanji Fang, Yifan Cao, Jieti Wang, Chao Lin, Hao Liu, Heng Zhang, Hongyong He, Ruochen Li, Jing Qin, He Li, Jiejie Xu
Intratumoral PD-1 + CD8 + T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer. British journal of cancer 127 (9) (2022)
Chang Xu, Hanji Fang, Yun Gu, Kuan Yu, Jieti Wang, Chao Lin, Heng Zhang, He Li, Hongyong He, Hao Liu, Ruochen Li
Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer. Cancer science (2022)
Puran Zhang, Yun Gu, Hanji Fang, Yifan Cao, Jieti Wang, Hao Liu, Heng Zhang, He Li, Hongyong He, Ruochen Li, Chao Lin, Jiejie Xu
Intratumoral IL-1R1 expression delineates a distinctive molecular subset with therapeutic resistance in patients with gastric cancer. Journal for immunotherapy of cancer 10 (2) (2022)
Ke Chen, Yun Gu, Yifan Cao, Hanji Fang, Kunpeng Lv, Xin Liu, Xudong He, Jieti Wang, Chao Lin, Hao Liu, Heng Zhang, Hongyong He, Jiejie Xu, He Li, Ruochen Li
TIM3+ cells in gastric cancer: clinical correlates and association with immune context. British journal of cancer (2021)
Siyu Xia, Yun Gu, Haijian Zhang, Yuchao Fei, Yifan Cao, Hanji Fang, Jieti Wang, Chao Lin, Heng Zhang, He Li, Hongyong He, Jiejie Xu, Ruochen Li, Hao Liu, Weijuan Zhang
Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer. Oncoimmunology 10 (1) (2021)